The upregulated CLC-3 in gliomas promotes NF-κB transactivity to regulate intracellular transcriptomic plasticity, alters matrix metalloproteinase such as MMP-3, MMP-9 expression, and actively modulates the extracellular environment. The gene discussed is NFKB1; the disease is central nervous system cancer.